位置:首页 > 产品库 > MAX-40279 hemifumarate
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
MAX-40279 hemifumarate
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
MAX-40279 hemifumarate图片
CAS NO:2388506-43-0
包装与价格:
包装价格(元)
5mg询价
10mg询价
25mg询价
50mg询价

MAX-40279 hemifumarate 是 FLT3 激酶和 FGFR 激酶的双重有效抑制剂。MAX-40279 hemifumarate 具有研究急性髓性白血病 (AML) 的潜力 (信息提取自专利 WO2021180032A1)。
Cas No.2388506-43-0
分子式C22H23FN6OS.1/2C4H4O4
分子量554.59
溶解度DMF : 1.96 mg/mL (3.53 mM; ultrasonic and warming and adjust pH to 5 with HCl and heat to 60℃)
储存条件-20°C, away from moisture
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

MAX-40279 hemifumarate is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 hemifumarate has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032)[1].

[1]. Yuguang Wang, et al. Novel Therapeutic Methods. Patent WO2021180032A1.

 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024